In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them
Eye contamination prevention requires careful application technique keeping products well away from lash line, washing hands before and after application, avoiding application with fingers that touched product bottle opening, and never applying products with eyes closed allowing migration into eyes
North Grand Rapids Longevity Clinic 4150 E Beltline Ave NE, Grand Rapids, MI 49525
and it has been shown to improve markers of dyslipidemia
A study on an adult population showed a prevalence of 2%, 1%, and 0.7% in the United States, the United Kingdom, and Canada, respectively.7 Likewise, an Argentinian study reported a prevalence of 1% in adolescents.8 The prevalence of CVS is unknown in the Mexican population but a study conducted on Mexican school-age children evaluated the prevalence of gut-brain axis disorders, and found a 0.3% prevalence of CVS in that selected group.9 CVS is more frequent in women and the mean adult age at presentation is 37 years
